P

Pyxis Oncology

78 employees

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Immuno-oncology and oncology
Pharmaceutical

Date founded

2019

Funding rounds raised

Total raised

$152M

from 12 investors over 12 rounds

P

Pyxis Oncology raised $152M on March 30, 2021

Investors: Leaps by Bayer, LifeSci Venture Partners, Tekla Capital Management, Logos Global Management, LP, RTW Investments, LP, Surveyor Capital, Ridgeback Capital Management LLC, Perceptive Advisors and Longwood Fund

P

Pyxis Oncology raised $22M on July 17, 2019

Investors: Leaps by Bayer, Longwood Fund and Agent Capital

FAQ